Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
Hiroki Ozawa, Rheumatologist at St.Luke’s International Hospital, shared a post on LinkedIn about a paper by Yuri Hiramatsu et al. published in Rheumatology:
“Real-World Data from Japan: Treat-to-Target Strategy in RA Pregnancy
Sharing new real-world evidence from the Japanese multicentre ANSWER cohort, which analyzed 118 pregnancies in women with rheumatoid arthritis (RA) and evaluated the impact of a treat-to-target (T2T) approach.
Key Insights from Japan
1․ T2T enables both disease control and healthy pregnancy outcomes
85% of patients maintained remission or low disease activity throughout pregnancy.
Tight control translated into excellent outcomes, including a 92.8% full-term delivery rate.
Continued use of pregnancy-compatible bDMARDs (e.g., etanercept, certolizumab pegol) was linked with lower disease activity during later trimesters.
2․ Salazosulfapyridine (SASP) shows a positive neonatal signal
Maternal SASP use in the third trimester was associated with higher birth weights (P=0.003) and a trend toward longer gestational ages (P=0.051).
While causality needs further confirmation, this real-world signal supports SASP as a potentially beneficial option during pregnancy.
Take-home message:
Individualized T2T strategies are feasible and effective in pregnant RA patients, supporting both maternal stability and optimal fetal health.
Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study | Rheumatology | Oxford Academic
For more research summaries and clinical insights, I share quick audio digests here:
Journal Note — Spotify Podcast”
Title: Effect of treat-to-target strategies on maternal and neonatal outcomes of rheumatoid arthritis: a multicentre real-world ANSWER cohort study
Authors: Yuri Hiramatsu, Takuya Kotani, Eri Nakamura, Ayaka Yoshikawa, Motomu Hashimoto, Akira Onishi, Kouichi Murata, Natsuki Yamamoto, Kosaku Murakami, Toru Hirano, Yuichi Maeda, Kosuke Ebina, Sho Sendo, Yonsu Son, Hideki Amuro, Ryota Hara, Masaki Katayama, Wataru Yamamoto, Tohru Takeuchi
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 3, 2026, 17:37Michael Chapman: Having Played a Part in the Evolution of IVF Has Been an Extraordinary Chapter of My Career
-
Nov 3, 2026, 17:36Sara Shikhman: Infertility Doesn’t Care How Hard You Work
-
Nov 3, 2026, 17:32Kathiuska Kriedt: What the National Fertility Awareness Week Means to Me
-
Nov 3, 2026, 17:31Saff Mitten: Grieving the Person You Were Before Infertility and IVF
-
Nov 3, 2026, 17:29Rajeev Agarwal: All Reports Normal, Still Not Pregnant?
-
Nov 3, 2026, 17:27When It Comes to RPL, More Treatment Does Not Always Mean Better Care – ESHRE SIG Reproductive Genetics
-
Nov 3, 2026, 17:24Eva van Rooijen: As A Mother Thanks to IVF, I Used to Think I Understood the Struggle…
-
Nov 3, 2026, 17:22What Would Work Look Like If People Didn’t Have to Choose Between Their Fertility Journey and Their Job? – ESHRE
-
Nov 3, 2026, 17:19Expert Fertility Care, Closer to Home in Salisbury – Complete Fertility